81 related articles for article (PubMed ID: 9494567)
1. Antitumor effectiveness of bolus versus split dose vinblastine treatment in EAT tumors in mice.
Cemazar M; Sersa G; Auersperg M
Anticancer Res; 1997; 17(6D):4553-6. PubMed ID: 9494567
[TBL] [Abstract][Full Text] [Related]
2. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
[TBL] [Abstract][Full Text] [Related]
3. The effect of recombinant human tumor necrosis factor-alpha on Ehrlich ascites tumor growth.
Terlikowski S; Sulkowska M; Nowak HF
J Environ Pathol Toxicol Oncol; 2002; 21(1):87-92. PubMed ID: 11934018
[TBL] [Abstract][Full Text] [Related]
4. Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model.
Kisker O; Becker CM; Prox D; Fannon M; D'Amato R; Flynn E; Fogler WE; Sim BK; Allred EN; Pirie-Shepherd SR; Folkman J
Cancer Res; 2001 Oct; 61(20):7669-74. PubMed ID: 11606410
[TBL] [Abstract][Full Text] [Related]
5. In vivo antitumor activity of the bitter melon (Momordica charantia).
Jilka C; Strifler B; Fortner GW; Hays EF; Takemoto DJ
Cancer Res; 1983 Nov; 43(11):5151-5. PubMed ID: 6616452
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of P-4055 (elaidic acid-cytarabine) compared to cytarabine in metastatic and s.c. human tumor xenograft models.
Breistøl K; Balzarini J; Sandvold ML; Myhren F; Martinsen M; De Clercq E; Fodstad O
Cancer Res; 1999 Jun; 59(12):2944-9. PubMed ID: 10383159
[TBL] [Abstract][Full Text] [Related]
7. In vivo antitumor activity of bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) (METVAN [VO(SO4)(Me2-Phen)2]).
Narla RK; Chen CL; Dong Y; Uckun FM
Clin Cancer Res; 2001 Jul; 7(7):2124-33. PubMed ID: 11448932
[TBL] [Abstract][Full Text] [Related]
8. Comparison of intraperitoneal continuous infusion of floxuridine and bolus administration in a peritoneal gastric cancer xenograft model.
Inoue K; Onishi H; Kato Y; Michiura T; Nakai K; Sato M; Yamamichi K; Machida Y; Nakane Y
Cancer Chemother Pharmacol; 2004 May; 53(5):415-22. PubMed ID: 15132129
[TBL] [Abstract][Full Text] [Related]
9. Thermoradiotherapy with hydralazine: the effect of preirradiation of the tumor bed on blood flow and growth delay of Ehrlich carcinoma.
Kozin SV; Kozina LV
Radiat Res; 1999 Jan; 151(1):79-84. PubMed ID: 9973088
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water.
Man S; Bocci G; Francia G; Green SK; Jothy S; Hanahan D; Bohlen P; Hicklin DJ; Bergers G; Kerbel RS
Cancer Res; 2002 May; 62(10):2731-5. PubMed ID: 12019144
[TBL] [Abstract][Full Text] [Related]
11. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma.
Köpf-Maier P
Anticancer Res; 1999; 19(1A):493-504. PubMed ID: 10226588
[TBL] [Abstract][Full Text] [Related]
13. Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study.
Samuels BL; Hollis DR; Rosner GL; Trump DL; Shapiro CL; Vogelzang NJ; Schilsky RL
Clin Cancer Res; 1997 Nov; 3(11):1977-84. PubMed ID: 9815587
[TBL] [Abstract][Full Text] [Related]
14. Demecolcin and vinblastine sulphate as stathmokinetic agents for different tissues of the hairless mouse.
Nome O
Pathol Eur; 1975; 10(3):221-31. PubMed ID: 1187199
[TBL] [Abstract][Full Text] [Related]
15. Ascitic and solid Ehrlich tumor inhibition by Chenopodium ambrosioides L. treatment.
Nascimento FR; Cruz GV; Pereira PV; Maciel MC; Silva LA; Azevedo AP; Barroqueiro ES; Guerra RN
Life Sci; 2006 Apr; 78(22):2650-3. PubMed ID: 16307762
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effect of Bothrops jararaca venom.
da Silva RJ; da Silva MG; Vilela LC; Fecchio D
Mediators Inflamm; 2002 Apr; 11(2):99-104. PubMed ID: 12061431
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents.
Studeny M; Marini FC; Dembinski JL; Zompetta C; Cabreira-Hansen M; Bekele BN; Champlin RE; Andreeff M
J Natl Cancer Inst; 2004 Nov; 96(21):1593-603. PubMed ID: 15523088
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae).
Da Silva SL; Chaar Jda S; Yano T
Eur J Pharmacol; 2009 Apr; 608(1-3):76-83. PubMed ID: 19222998
[TBL] [Abstract][Full Text] [Related]
19. Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts.
Green DW; Roh H; Pippin JA; Drebin JA
J Surg Res; 2001 Nov; 101(1):16-20. PubMed ID: 11676549
[TBL] [Abstract][Full Text] [Related]
20. Acute in vivo resistance in high-dose therapy.
Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
